What are the medical device stocks with the highest dividends?

Medical device stocks with especially high dividend yields include Koninklijke Philips NV (NYSE:PHG) and Medtronic (NYSE:MDT).

Are medical device stocks a good buy now?

Some medical device stocks are good choices to buy now. Consider individual medical device stocks' valuations, growth prospects, and market positioning before buying.

What are the top medical device companies?

The top medical device companies based on market cap include Johnson & Johnson (NYSE:JNJ), Abbott Laboratories (NYSE:ABT), and Intuitive Surgical (NASDAQ:ISRG).

What are the most undervalued medical device stocks?

Some of the most undervalued medical device stocks based on forward price-to-earnings ratios include Integra LifeSciences Holdings (NASDAQ:IART), AdaptHealth (NASDAQ:AHCO), and InMode (NASDAQ:INMD).

How big is the medical devices market in ##year##?

The global medical device market is projected to reach around $720 billion in ##year##, according to Precedence Research.

Are small-cap medical device stocks more profitable than large-cap ones?

The answer depends on what is meant by "profitable." Large-cap medical device stocks typically generate higher profit margins than small-cap medical device stocks. However, investing in small-cap medical device stocks with tremendous growth potential can deliver greater investing profits in some cases compared to investing in mature, large-cap medical device stocks.

What is the fastest-growing medical device market?

In 2025, pulsed-field ablation devices used to treat atrial fibrillation were the fastest-growing medical device market, according to Life Science Intelligence.

Best Medical Device Stocks for 2026 and How to Invest

By Keith Speights – Updated Feb 16, 2026 at 5:57 PM EST | Fact-checked by Frank Bass

Key Points

Medical device market to grow to $1.2 trillion by 2034, increasing investment appeal.
Top medical device stocks include Abbott, GE Healthcare, and Intuitive Surgical.
Investing steps: open brokerage app, search stock, decide shares, submit order.

Loading paragraph...

Ticker Information Table
Name and ticker	Current price	Market cap	Dividend yield
Abbott Laboratories (NYSE:ABT)	$109.73	$190.4 billion	2.19%
GE HealthCare Technologies (NASDAQ:GEHC)	$74.27	$33.8 billion	0.19%
Intuitive Surgical (NASDAQ:ISRG)	$491.04	$174.1 billion	0.00%
Johnson & Johnson (NYSE:JNJ)	$240.66	$579.3 billion	2.16%
TransMedics Group (NASDAQ:TMDX)	$129.30	$4.4 billion	0.00%

Data as of Mar 7, 2026. Showing 5 of 5 tickers.

Loading ticker_table...

Loading paragraph...

NYSE: ABT

Abbott Laboratories

Today's Change

(-1.18%) $-1.31

Current Price

$109.73

Key Data Points

Market Cap

$190B

Day's Range

$108.35 - $110.97

52wk Range

$105.27 - $139.15

Volume

431K

Avg Vol

9.3M

Gross Margin

52.72%

Dividend Yield

2.19%

Loading company_card...

Abbott Laboratories (ABT -1.18%) is a large-cap company that makes medical devices, including continuous glucose monitoring (CGM) systems, defibrillators, heart failure monitoring systems, mechanical heart valves, pacemakers, and spinal cord stimulators. It also operates multibillion-dollar business segments that market established pharmaceuticals, diagnostics systems, and nutritional products.

The COVID-19 pandemic provided a huge boost to Abbott's fortunes, thanks to the company's rapid diagnostic tests. Although the company's overall revenue declined as demand for the tests waned, Abbott's base business remains strong. In particular, Abbott's FreeStyle Libre stands out as a key growth driver. It's the top-selling CGM device in the world, with soaring sales.

Income investors may find Abbott especially attractive. It's a Dividend King with 54 consecutive years of dividend increases.

Loading paragraph...

2. GE Healthcare Technologies

Loading paragraph...

NASDAQ: GEHC

GE HealthCare Technologies

Today's Change

(-3.68%) $-2.84

Current Price

$74.27

Key Data Points

Market Cap

$34B

Day's Range

$74.19 - $75.78

52wk Range

$57.65 - $89.77

Volume

84K

Avg Vol

3.3M

Gross Margin

39.70%

Dividend Yield

0.19%

Loading company_card...

Loading paragraph...

NASDAQ: ISRG

Intuitive Surgical

Today's Change

(-1.14%) $-5.66

Current Price

$491.04

Key Data Points

Market Cap

$174B

Day's Range

$478.25 - $491.06

52wk Range

$425.00 - $603.88

Volume

97K

Avg Vol

1.9M

Gross Margin

65.98%

Loading company_card...

Intuitive Surgical (ISRG -1.14%) is a large-cap company that pioneered the development of minimally invasive robotic surgical systems. The company launched its flagship da Vinci surgical system in 1999. Da Vinci was first approved for use in general laparoscopic surgery, but today it is used in a wide range of procedures.

More than 20.4 million procedures have been performed using da Vinci systems, with roughly 3.2 million of those procedures done in 2025. More than 12,000 da Vinci systems are installed in hospitals across the world.

Aside from a temporary slowdown during the COVID-19 pandemic, Intuitive Surgical's procedure volumes have grown steadily in recent years, boosting the company's recurring revenue from selling replacement instruments. In 2025, recurring revenue made up 84% of Intuitive's total revenue.

Aging trends should help Intuitive Surgical by driving increased demand for surgical procedures. The company also continues to enhance its robotic surgical systems so that they can be used for additional types of procedures.

4. Johnson & Johnson

Loading paragraph...

NYSE: JNJ

Johnson & Johnson

Today's Change

(0.43%) $1.03

Current Price

$240.66

Key Data Points

Market Cap

$579B

Day's Range

$235.45 - $240.81

52wk Range

$141.50 - $251.71

Volume

303K

Avg Vol

8.9M

Gross Margin

67.97%

Dividend Yield

2.16%

Loading company_card...

Johnson & Johnson (JNJ +0.43%) is a large-cap company that ranks as one of the world's biggest medical device makers. It markets medical devices that include catheters, implants, robotic surgical systems, surgical instruments, and wound closure products. J&J is also a top maker of prescription drugs.

Acquisitions have played a big role in helping Johnson & Johnson grow its medical device business. In recent years, the healthcare giant has acquired several medtech companies, including Abiomed and Verb Surgical.

Johnson & Johnson spun off its consumer health unit into a separate publicly traded entity, Kenvue (KVUE +0.77%), in May 2023. The move could enable the company to deliver even stronger long-term growth.

The stock remains a favorite for income investors, too. J&J has increased its dividend for an impressive 63 consecutive years, making it one of the top Dividend Kings in the market.

Loading paragraph...

5. TransMedics Group

Loading paragraph...

NASDAQ: TMDX

TransMedics Group

Today's Change

(-7.69%) $-10.77

Current Price

$129.30

Key Data Points

Market Cap

$4.4B

Day's Range

$128.76 - $137.69

52wk Range

$62.23 - $156.00

Volume

47K

Avg Vol

782K

Gross Margin

59.87%

Loading company_card...

Loading paragraph...

Medical device stocks FAQ

Loading faq...

About the Author

Keith Speights is a contributing Motley Fool healthcare analyst covering publicly traded companies across pharmaceuticals, biotechnology, medical devices, technology, and marijuana. Prior to The Motley Fool, Keith was CEO of Constant Care Technology, a healthcare technology company; vice president of American HealthTech, a healthcare software company; and a director of operations for Blue Cross Blue Shield of Mississippi, a health insurer. He holds a B.S. in Industrial Engineering from Mississippi State University.

TMFFishBiz

Keith Speights has positions in Intuitive Surgical. The Motley Fool has positions in and recommends Abbott Laboratories, GE HealthCare Technologies, Intuitive Surgical, Kenvue, and TransMedics Group. The Motley Fool recommends Johnson & Johnson and recommends the following options: long January 2028 $520 calls on Intuitive Surgical and short January 2028 $530 calls on Intuitive Surgical. The Motley Fool has a disclosure policy.